Funding A Solution: aMoon Managing Director Dr. Gur Roshwalb Q&A

Funding A Solution: aMoon Managing Director Dr. Gur Roshwalb Q&A

Dr. Gur Roshwalb, a former medical practitioner and now managing director at aMoon, a health technology and life sciences venture fund, discusses how Covid-19 is changing biotech investing, what he looks for as an investor and which new sectors are gaining momentum.


FDI Faces Covid Crackdown

FDI Faces Covid Crackdown

Multiple governments in recent years have amended existing legislation or adopted new regulatory processes to better screen or block FDI, if necessary.



Berkshire Hathaway Names Buffett's Successors

Longtime senior executives Greg Abel and Ajit Jain were promoted to vice chairman on January 10 and joined Berkshire’s board of directors. The announcement might suggest that Abel and Jain, alone or together, might lead the company in the near future.

South Korea Engages With North Korea

South Korea’s new overtures to Kim Jong II are part of a broader regional diplomatic initiative. Moon visited China, a North Korean ally and key trading partner, in December 2017, and called for better South Korea-China relations.


The Benefits Of Blockchain

Jalak Jobanputra, founding partner of Future\Perfect Ventures, an early-stage venture-capital fund, visited Global Finance to discuss the state of fintech, the future of blockchain and digital currencies, and how corporations can extract more value from such technology.


Can New CEO End Crisis For Teva Pharmaceutical

Kåre Schultz will take over as CEO at a time when the pharmaceutical company struggles with competition, downward pressure on drug prices, expiring patents, rising operational costs, bribery investigations, fines and failed acquisitions.